Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAM
3301
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $1.16M | ﹤0.01% |
81,157
+31,017
| +62% | +$442K |
|
3302
Nektar Therapeutics
NKTR
$884M
| $1.15M | ﹤0.01% |
135,974
+5,617
| +4% | +$47.6K |
|
3303
Lunai Bioworks Inc. Common Stock
RENB
$46.6M
| $1.15M | ﹤0.01% |
362,409
+59,315
| +20% | +$188K |
|
3304
OPAL Fuels
OPAL
$65M
| $1.15M | ﹤0.01% |
207,776
+22,242
| +12% | +$123K |
|
3305
Rigetti Computing
RGTI
$5.26B
| $1.15M | ﹤0.01% |
1,162,612
+94,512
| +9% | +$93.1K |
|
3306
Trevi Therapeutics
TRVI
$1.19B
| $1.14M | ﹤0.01% |
849,881
+62,241
| +8% | +$83.4K |
|
3307
Cellebrite
CLBT
$4.27B
| $1.14M | ﹤0.01% |
131,498
+480
| +0.4% | +$4.16K |
|
|
ARC
3308
DELISTED
ARC Document Solutions, Inc.
ARC
| $1.13M | ﹤0.01% |
345,136
+17,481
| +5% | +$57.4K |
|
|
CBIO
3309
Crescent Biopharma, Inc. Common Stock
CBIO
$177M
| $1.13M | ﹤0.01% |
4,789
+191
| +4% | +$45.1K |
|
3310
1stdibs.com
DIBS
$102M
| $1.13M | ﹤0.01% |
240,560
+28,350
| +13% | +$133K |
|
|
VXRT
3311
DELISTED
Vaxart
VXRT
| $1.12M | ﹤0.01% |
1,962,033
+175,398
| +10% | +$100K |
|
3312
TELUS International
TIXT
$1.25B
| $1.12M | ﹤0.01% |
108,503
+11,379
| +12% | +$118K |
|
3313
United Homes Group
UHG
$256M
| $1.12M | ﹤0.01% |
132,919
-3,418
| -3% | -$28.8K |
|
3314
Crawford & Co Class B
CRD.B
$504M
| $1.12M | ﹤0.01% |
85,415
+3,022
| +4% | +$39.5K |
|
3315
Eldorado Gold
EGO
$5.62B
| $1.12M | ﹤0.01% |
85,966
-1,532
| -2% | -$19.9K |
|
|
LL
3316
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.12M | ﹤0.01% |
286,091
+2,695
| +1% | +$10.5K |
|
3317
Priority Technology Holdings
PRTH
$614M
| $1.12M | ﹤0.01% |
313,274
| – | – |
|
3318
LiveOne
LVO
$61.3M
| $1.11M | ﹤0.01% |
798,951
+29,538
| +4% | +$41.1K |
|
3319
System1
SST
$68.1M
| $1.11M | ﹤0.01% |
49,989
+767
| +2% | +$17K |
|
3320
Veritone
VERI
$179M
| $1.11M | ﹤0.01% |
613,056
+14,705
| +2% | +$26.6K |
|
3321
Atara Biotherapeutics
ATRA
$85.3M
| $1.1M | ﹤0.01% |
86,006
+2,943
| +4% | +$37.7K |
|
3322
American Outdoor Brands
AOUT
$113M
| $1.1M | ﹤0.01% |
131,191
+5,316
| +4% | +$44.7K |
|
3323
Abeona Therapeutics
ABEO
$348M
| $1.1M | ﹤0.01% |
219,385
+22,646
| +12% | +$113K |
|
3324
Nuvectis Pharma
NVCT
$164M
| $1.1M | ﹤0.01% |
131,657
+1,994
| +2% | +$16.6K |
|
3325
Baytex Energy
BTE
$1.83B
| $1.09M | ﹤0.01% |
331,070
+72,784
| +28% | +$241K |
|